Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids

Clinical Biochemistry

Volumn 43, Issue 4-5, 2010, Pages 424-429

  Kalpravidh, Ruchaneekorn W ^a   Siritanaratkul, Noppadol ^a   Insain, Praphaipit ^a   Charoensakdi, Ratiya ^a   Panichkul, Narumol ^a   Hatairaktham, Suneerat ^a   Srichairatanakool, Somdet ^b   Phisalaphong, Chada ^c   Rachmilewitz, Eliezer ^d   Fucharoen, Suthat ^e  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

^c Thailand Government Pharmaceutical Organization   (Thailand)

^d WOLFSON MEDICAL CENTER   (Israel)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

thalassemia Hb E; Antioxidant; Antioxidant enzymes; Curcuminoids; Oxidative stress

Indexed keywords

ANTIOXIDANT; CURCUMINOID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN E; IRON BINDING PROTEIN; MALONALDEHYDE; METHEMOGLOBIN; NON TRANSFERRIN BOUND IRON; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BETA THALASSEMIA; BLOOD ANALYSIS; BLOOD CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; ERYTHROCYTE LEVEL; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTIOXIDANTS; BETA-THALASSEMIA; CURCUMIN; ENZYME INHIBITORS; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN E; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; YOUNG ADULT;

EID: 76749103354     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.10.057     Document Type: Article

References (63)

1. Weatherall D.J. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat. Rev. Genet. 2 (2001) 245-255
2. Rachmilewitz E.A., Weizer-Stern O., Adamsky K., et al. Role of iron in inducing oxidative stress in thalassemia: can it be prevented by inhibition of absorption and by antioxidants?. Ann. N.Y. Acad. Sci. 1054 (2005) 118-123
3. Rund D., and Rachmilewitz E. Beta-thalassemia. N. Engl. J. Med. 353 (2005) 1135-1146
4. Nemeth E., and Ganz T. Hepcidin and iron-loading anemias. Haematologica 91 (2006) 727-732
5. Kohgo Y., Ikuta K., Ohtake T., Torimoto Y., and Kato J. Body iron metabolism and pathophysiology of iron overload. Int. J. Hematol. 88 (2008) 7-15
6. Fucharoen S., Ketvichit P., Pootrakul P., Siritanaratkul N., Piankijagum A., and Wasi P. Clinical manifestation of beta-thalassemia/hemoglobin E disease. J. Pediatr. Hematol. Oncol. 22 (2000) 552-557
7. Itokawa H., Shi Q., Akiyama T., Morris-Natschke S.L., and Lee K.H. Recent advances in the investigation of curcuminoids. Chin. Med. 3 (2008) 11
8. Calabrese V., Bates T.E., Mancuso C., et al. Curcumin and the cellular stress response in free radical-related diseases. Mol. Nutr. Food Res. 52 (2008) 1062-1073
9. Hatcher H., Planalp R., Cho J., Torti F.M., and Torti S.V. Curcumin: from ancient medicine to current clinical trials. Cell. Mol. Life Sci. 65 (2008) 1631-1652
10. Pari L., Tewas D., and Eckel J. Role of curcumin in health and disease. Arch. Physiol. Biochem. 114 (2008) 127-149
11. Strimpakos A.S., and Sharma R.A. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid. Redox Signal. 10 (2008) 511-545
12. Verma R.J., and Mathuria N. Curcumin ameliorates aflatoxin-induced lipid-peroxidation in liver and kidney of mice. Acta Pol. Pharm. 65 (2008) 195-202
13. Villegas I., Sanchez-Fidalgo S., and Alarcon de la Lastra C. New mechanisms and therapeutic potential of curcumin for colorectal cancer. Mol. Nutr. Food Res. 52 (2008) 1040-1061
14. Jiao Y., Wilkinson J., Christine Pietsch E., et al. Iron chelation in the biological activity of curcumin. Free Radic. Biol. Med. 40 (2006) 1152-1160
15. Ak T., and Gulcin I. Antioxidant and radical scavenging properties of curcumin. Chem. Biol. Interact. 174 (2008) 27-37
16. Srichairatanakool S., Thephinlap C., Phisalaphong C., Porter J.B., and Fucharoen S. Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma. Med. Chem. 3 (2007) 469-474
17. Kalpravidh RW, Fucharoen S, Siritanaratkul N, et al. Oxidative stress and the effects of antioxidants in thalassemia. The 8th International Conference on Thalassemia and the Hemoglobinopathies. Greece; 2001. p 121.
18. Stocks J., and Dormandy T.L. The autoxidation of human red cell lipids induced by hydrogen peroxide. Br. J. Haematol. 20 (1971) 95-111
19. Winterbourn C.C., Hawkins R.E., Brian M., and Carrell R.W. The estimation of red cell superoxide dismutase activity. J. Lab. Clin. Med. 85 (1975) 337-341
20. Beutler E. Red cell metabolism: a manual of biochemical methods (1984), Grune&Stratton, London 74-76
21. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106 (1980) 207-212
22. Evelyn K.A., and Molly H. Microdetermination of oxyhemoglobin, methemoglobin and sulfhemoglobin in a single sample of blood. J. Biol. Chem. 126 (1983) 655-662
23. Singh S., Hider R.C., and Porter J.B. A direct method for quantification of non-transferrin-bound iron. Anal. Biochem. 186 (1990) 320-323
24. Fibach E., and Rachmilewitz E. The role of oxidative stress in hemolytic anemia. Curr. Mol. Med. 8 (2008) 609-619
25. Kukongviriyapan V., Somparn N., Senggunprai L., Prawan A., Kukongviriyapan U., and Jetsrisuparb A. Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-beta thalassemia. Pediatr. Cardiol. 29 (2008) 130-135
26. Loebstein R., Lehotay D.C., Luo X., Bartfay W., Tyler B., and Sher GD. Diabetic nephropathy in hypertransfused patients with beta-thalassemia. The role of oxidative stress. Diabetes Care 21 (1998) 1306-1309
27. Hershko C., Link G., and Cabantchik I. Pathophysiology of iron overload. Ann. N.Y. Acad. Sci. 850 (1998) 191-201
28. Cighetti G., Duca L., Bortone L., et al. Oxidative status and malondialdehyde in beta-thalassaemia patients. Eur. J. Clin. Invest. 32 Suppl 1 (2002) 55-60
29. Kalpravidh R.W., Wichit A., Siritanaratkul N., and Fucharoen S. Effect of coenzyme Q10 as an antioxidant in beta-thalassemia/Hb E patients. Biofactors 25 (2005) 225-234
30. Chiou S.S., Chang T.T., Tsai S.P., et al. Lipid peroxidation and antioxidative status in beta-thalassemia major patients with or without hepatitis C virus infection. Clin. Chem. Lab. Med. 44 (2006) 1226-1233
31. Naithani R., Chandra J., Bhattacharjee J., Verma P., and Narayan S. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major. Pediatric Blood Cancer 46 (2006) 780-785
32. Walter P.B., Fung E.B., Killilea D.W., et al. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br. J. Haematol. 135 (2006) 254-263
33. Matayatsuk C., Poljak A., Bustamante S., et al. Quantitative determination of ortho- and meta-tyrosine as biomarkers of protein oxidative damage in beta-thalassemia. Redox. Rep. 12 (2007) 219-228
34. Grinberg L.N., Shalev O., Tonnesen H.H., and Rachmilewitz EA. Studies on curcumin and curcuminoids: XXVI. Antioxidant effects of curcumin on the red blood cell membrane. Int. J. Pharm. 132 (1996) 251-257
35. Frie B., Kim B.C., and Ames B.N. Ubiquinol-10 is an effective lipid soluble antioxidant at physiological concentrations. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 4879-4883
36. Vatanavicharn S., A.M., Yenchitsomanus P., and Siddhikol C. Relationship of serum vitamin E, erythrocyte nonheme iron, and malonyldialdehyde (lipid membrane peroxidation product) in thalassemia. Birth Defects Orig. Artic. Ser. 23 5A (1987) 207-211
37. Fiorelli G., D.F.T., Duca L., Tavazzi D., Nava I., Fargion S., and Cappellini M.D. Red blood cell antioxidant and iron status in alcoholic and nonalcoholic cirrhosis. Eur. J. Clin. Invest. Suppl 1 (2002) 21-27
38. Jacobs E.M., Hendriks J.C., van Tits B.L., et al. Results of an international round robin for the quantification of serum non-transferrin-bound iron: need for defining standardization and a clinically relevant isoform. Anal. Biochem. 341 (2005) 241-250
39. Wickramasinghe S.N., Thein S.L., Srichairatanakool S., and Porter J.B. Determinants of iron status and bilirubin levels in congenital dyserythropoietic anaemia type I. Br. J. Haematol. 107 (1999) 522-525
40. Porter J.B., Abeysinghe R.D., Marshall L., Hider R.C., and Singh S. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. Blood 88 (1996) 705-713
41. Hershko C. Iron loading and its clinical implications. Am. J. Hematol. 82 (2007) 1147-1148
42. Kassab-Chekir A., Laradi S., Ferchichi S., et al. Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin. Chim. Acta; Intl. J. Clin. Chem. 338 (2003) 79-86
43. Meral A., Tuncel P., Surmen-Gur E., Ozbek R., Ozturk E., and Gunay U. Lipid peroxidation and antioxidant status in beta-thalassemia. Pediatr. Hematol. Oncol. 17 (2000) 687-693
44. Prasartkaew S., Bunyaratvej A., Fucharoen S., and Wasi P. Comparison of erythrocyte antioxidative enzyme activities between two types of haemoglobin H disease. J. Clin. Pathol. 39 (1986) 1299-1303
45. Amer J., Atlas D., and Fibach E. N-acetylcysteine amide (AD4) attenuates oxidative stress in beta-thalassemia blood cells. Biochim. Biophys. Acta 1780 (2008) 249-255
46. Amer J., Goldfarb A., Rachmilewitz E.A., and Fibach E. Fermented papaya preparation as redox regulator in blood cells of beta-thalassemic mice and patients. Phytother. Res. 22 (2008) 820-828
47. Tesoriere L., D'Arpa D., Butera D., et al. Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in beta-thalassemia intermedia patients. Free Radic. Res. 34 (2001) 529-540
48. Cheng A.L., Hsu C.H., Lin J.K., et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21 (2001) 2895-2900
49. Lao C.D. Ruffin MTt, Normolle D, et al. Dose escalation of a curcuminoid formulation. BMC Complement. Altern. Med. 6 (2006) 10
50. Benassi R., Ferrari E., Grandi R., Lazzari S., and Saladini M. Synthesis and characterization of new beta-diketo derivatives with iron chelating ability. J. Inorg. Biochem. 101 (2007) 203-213
51. Bernabe-Pineda M., Ramirez-Silva M.T., Romero-Romo M.A., Gonzalez-Vergara E., and Rojas-Hernandez A. Spectrophotometric and electrochemical determination of the formation constants of the complexes Curcumin-Fe(III)-water and Curcumin-Fe(II)-water. Spectrochim. Acta A. Mol. Biomol. Spectrosc. 60 (2004) 1105-1113
52. Rahman I., and Adcock I.M. Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J. 28 (2006) 219-242
53. Garg R., Gupta S., and Maru G.B. Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[a]pyrene-treated mice: mechanism of its anti-initiating action. Carcinogenesis 29 (2008) 1022-1032
54. Yang C., Zhang X., Fan H., and Liu Y. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res. 1282 (2009) 133-141
55. Nguyen T., Sherratt P.J., Nioi P., Yang C.S., and Pickett C.B. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J. Biol. Chem. 280 (2005) 32485-32492
56. Lee J.S., and Surh Y.J. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. 224 (2005) 171-184
57. Venkatesan P., and Rao M.N. Structure-activity relationships for the inhibition of lipid peroxidation and the scavenging of free radicals by synthetic symmetrical curcumin analogues. J. Pharm. Pharmacol. 52 (2000) 1123-1128
58. Biswas S.K., McClure D., Jimenez L.A., Megson I.L., and Rahman I. Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid. Redox Signal. 7 (2005) 32-41
59. Banerjee A., Kunwar A., Mishra B., and Priyadarsini K.I. Concentration dependent antioxidant/pro-oxidant activity of curcumin studies from AAPH induced hemolysis of RBCs. Chem. Biol. Interact. 174 (2008) 134-139
60. Anand P., Kunnumakkara A.B., Newman R.A., and Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 4 (2007) 807-818
61. Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., and Srinivas P.S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta. Med. 64 (1998) 353-356
62. Buss J.L., Torti F.M., and Torti S.V. The role of iron chelation in cancer therapy. Curr. Med. Chem. 10 (2003) 1021-1034
63. Subudhi U., Das K., Paital B., Bhanja S., and Chainy G.B. Alleviation of enhanced oxidative stress and oxygen consumption of l-thyroxine induced hyperthyroid rat liver mitochondria by vitamin E and curcumin. Chem. Biol. Interact. 173 (2008) 105-114